Brief: Cambridge Cognition Expands Partnership With Actinogen
16/01/2025 07:12
Jan 16 (Reuters) - Cambridge Cognition Holdings PLC
COGC.L :
* EXPANDED PARTNERSHIP WITH ACTINOGEN
* EXPANDS PARTNERSHIP WITH ACTINOGEN FOR PHASE 2B/3 XANAMIA
ALZHEIMER'S DISEASE TRIAL
Source text: ID:nRSP5116Ta
Further company coverage: COGC.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cambridge Cognition Holdings
See all newsRCS - Cambridge Cognition - COG joins Imperial College-led NHS Study
Cambridge Cognition - Director/PDMR Share Purchases
RCS - Cambridge Cognition - Partnership with C2N and The Alzheimer's Trust
Brief: Cambridge Cognition Sees Annual Revenue Not Less Than £10 Mln
UK's Cambridge Cognition H1 revenue rises 16%, debt repaid